TRANSDERMAL DRUG DELIVERY: INNOVATIONS, CHALLENGES, AND FUTURE DIRECTIONS

Sushmita Das

doi:10.55640/

Open Access

TRANSDERMAL DRUG DELIVERY: INNOVATIONS, CHALLENGES, AND FUTURE DIRECTIONS

https://doi.org/10.55640/

pdf

Sushmita Das ¹ ,

⁴ Noida Institute of Engineering and Technology, Pharmacy Institute, 19, Knowledge Park-II, Greater Noida, Uttar Pradesh, India

Abstract

Transdermal drug delivery systems (TDDS) offer a non-invasive route for drug administration, providing numerous benefits such as improved patient compliance and controlled drug release. This review aims to explore the recent innovations in TDDS, highlighting advancements in technology, formulation strategies, and application areas. We discuss various innovations, including microneedle arrays, iontophoresis, and nanocarrier-based systems, which have enhanced drug permeation and therapeutic efficacy. Despite these advancements, several challenges persist, such as skin irritation, limited drug loading capacity, and variability in drug absorption. The review also addresses these challenges and presents potential solutions. Looking forward, future directions in TDDS are examined, emphasizing the integration of personalized medicine, smart drug delivery systems, and advancements in biocompatible materials. This comprehensive review provides valuable insights for researchers, practitioners, and industry professionals aiming to advance the field of transdermal drug delivery.

Keywords

Transdermal Drug Delivery, Innovations, Drug Delivery Systems

References

📄 Chien Y W (1987), “Novel Drug DeliverySys tems ”, 2n d Edition , Drugs a ndPharmaceutical Sciences, Marcel Dekker,Inc.washington, DC, Vol. 50, pp. 281-299.

📄 Finnin B C and Morgan T M (1999),“Transdermal Penetration”, J Pharm Sci.,Vol. 88, No. 10, pp. 955-958.

📄 Allen L V, Popovich N G and Ansel H C,(2005), Ansel’s Pharmaceutical DosageForms and Drug Delivery Systems, 8thEdition, Lippincott Williams &Wilkins, pp.298-315.

📄 Barry B (2002), Transdermal Drug Delivery,in Ed: Aulton M E, Pharmaceutics: TheScience of Dosage Form Design, ChurchillLivingston, pp :499-533.

📄 Enclyopedia of Polymer Science andTechnology, Interscience Publishers, Adivision of John Wiley and sons. Inc., 1976,Vol. 12, pp. 139-168.

📄 Barry B W (1987), “Mode of Action ofPenetration Enhancers in Human Skin”, JControl. Release, Vol. 6, pp. 85-97.

📄 Keith A D (1983 ), “Poly mer MatrixConsideration for Transdermal Devices”,Drug Dev Ind., Vol. 9, pp. 605-621.

📄 FitzGerald G A and Patrono C (2001), “TheCo xibs , Se lect ive Inh ibit ors ofCyclooxygenase-2”, N Engl J Med. Vol. 345,No. 6, pp. 433-442.

📄 Aquil M, Ali A, Sultana Y, Najmi A K (2004),“Fabrication and Evaluation of PolymericFilms for Transdermal Delivery of Pinacidil:Pharmazie”, Vol. 59, pp. 631-635.

📄 Arabi H, Hashemi SA, Ajdari N (2002),“Preparation of a Transdermal DeliverySystem and Effect of Membrane Type forScopolamine Drug”, Iranian Polymer J., Vol.11, No. 4, pp. 245- 249.

📄 Hock S Tan, William R Pfister (1999),“Pressu re-s ensitive Adh esiv es f orTransdermal Drug Delivery Systems”,PSTT, Vol. 2, pp. 60-69.

📄 Qvist M H, Hoeck U, Kreilgaard B, MadsonF and Frokjaer S (2002), “Release ofChemical Penetration Enhancers FromDrug-In-Adhesive Transdermal Patches”, IntJ Pharm., Vol. 231, pp. 253-263.

📄 Arcangelo, Virginia P, Peterson, Andrew M(20 05), “Ph arma coth erap eutics f orAdvanced Practice”, Published by LippincottWilliams & Wilkins, p. 74.

📄 Eseldin Keleb, Rakesh Kumar Sharma,Esmaeil B Mosa, Abd-alkadar Z aljahwi(20 10), “Transd erma l Drug Deliv erySystem-Design and Evaluation”, Int. J. ofAdvances in Pharm. Sci., Vol. 1, pp. 201-211.

📄 Vyas S P and Khar R K (2002), “ControlledDrug Delivery: Concepts and Advances,Vallabh Prakashan”, 1st Edition, pp. 411-447.

How to Cite

Sushmita Das. (2024). TRANSDERMAL DRUG DELIVERY: INNOVATIONS, CHALLENGES, AND FUTURE DIRECTIONS. Global Journal of Medical and Pharmaceutical Sciences, 3(09), 7-12. https://doi.org/10.55640/